RCEL Logo

AVITA Medical, Inc. (RCEL) 

NASDAQ
Market Cap
$205.11M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
201 of 809
Rank in Industry
26 of 107

Largest Insider Buys in Sector

RCEL Stock Price History Chart

RCEL Stock Performance

About AVITA Medical, Inc.

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

Insider Activity of AVITA Medical, Inc.

Over the last 12 months, insiders at AVITA Medical, Inc. have bought $255,295 and sold $147,742 worth of AVITA Medical, Inc. stock.

On average, over the past 5 years, insiders at AVITA Medical, Inc. have bought $80,451 and sold $960,564 worth of stock each year.

Highest buying activity among insiders over the last 12 months: O'Toole David D (CFO) — $1.02M.

The last purchase of 1,000 shares for transaction amount of $8,900 was made by O'Toole David D (CFO) on 2024‑05‑30.

List of Insider Buy and Sell Transactions, AVITA Medical, Inc.

2024-05-30PurchaseO'Toole David DCFO
1,000
0.0037%
$8.90$8,900-4.63%
2024-02-28PurchaseO'Toole David DCFO
1,250
0.005%
$17.39$21,738-45.76%
2023-12-26SaleCORBETT JAMESCEO
1,445
0.0057%
$13.29$19,204+0.87%
2023-12-21SaleCOOK JEREMY CURNOCKdirector
2,500
0.01%
$12.49$31,225+11.41%
2023-12-13SaleCOOK JEREMY CURNOCKdirector
2,518
0.0095%
$12.27$30,896+4.98%
2023-12-12PurchaseO'Toole David DCFO
950
0.0039%
$12.45$11,828+12.44%
2023-12-01PurchaseO'Toole David DCFO
500
0.0019%
$10.68$5,340+20.10%
2023-11-21PurchaseO'Toole David DCFO
2,000
0.008%
$10.28$20,560+29.22%
2023-11-16PurchaseO'Toole David DCFO
1,000
0.0038%
$12.15$12,150+3.10%
2023-11-15PurchaseO'Toole David DCFO
2,000
0.0078%
$12.85$25,700-0.23%
2023-11-15PurchaseO'Toole David DCFO
1,000
0.0038%
$12.45$12,450-0.23%
2023-11-14PurchaseO'Toole David DCFO
1,000
0.0037%
$12.88$12,880-3.50%
2023-08-21SaleShiroma DonnaGeneral Counsel
4,193
0.0162%
$15.84$66,417-20.72%
2023-08-16PurchaseO'Toole David DCFO
2,000
0.0081%
$17.05$34,110-22.18%
2023-08-15PurchaseO'Toole David DCFO
5,000
0.0201%
$17.93$89,640-26.19%
2023-06-20PurchaseO'Toole David DCFO
1,000
0.004%
$16.15$16,150-11.58%
2022-02-24SalePERRY MICHAEL SChief Executive Officer
10,812
0.0423%
$8.74$94,497-27.15%
2021-09-20PurchaseCrowe Suzannedirector
1,066
0.0043%
$17.08$18,207-50.62%
2021-09-01SalePERRY MICHAEL SChief Executive Officer
11,220
0.0447%
$20.68$232,030-57.95%
2021-06-02SalePERRY MICHAEL SChief Executive Officer
23,000
0.0925%
$17.33$398,590-22.22%

Insider Historical Profitability

<0.0001%
Shiroma DonnaGeneral Counsel
42257
0.1701%
$7.9501
COOK JEREMY CURNOCKdirector
20614
0.083%
$7.9502
O'Toole David DCFO
19734
0.0704%
$7.95120<0.0001%
CORBETT JAMESCEO
11580
0.0466%
$7.9501
PERRY MICHAEL SChief Executive Officer
321712
1.295%
$7.9508
Crowe Suzannedirector
4112
0.0166%
$7.9510<0.0001%
McIntyre DavidChief Financial Officer
893
0.0036%
$7.9520<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$28.05M6.781.75M-3.13%-$906,801.06<0.01
The Vanguard Group$22.57M5.461.41M+1.1%+$246,156.68<0.0001
State Street$15.08M3.65941,041+88.09%+$7.06M<0.01
Geode Capital Management$8.71M2.11543,016+2.72%+$230,207.68<0.01
Awm Investment Company Inc$7.97M1.93496,9520%+$01.18
Silvercrest Asset Management Group Inc$3.87M0.94241,665New+$3.87M0.03
Northern Trust$3.5M0.85218,134-3.13%-$112,947.38<0.01
Centerbook Partners Lp$2.33M0.56145,347+751.08%+$2.06M0.16
BNY Mellon$1.72M0.42107,608-7.77%-$145,392.16<0.0001
AQR Capital$1.45M0.3590,600+45.64%+$455,107.73<0.01
Goldman Sachs$1.3M0.3180,905+191.36%+$851,786.01<0.0001
GlobeFlex Capital$1.23M0.376,8560%+$00.12
Soleus Capital Management, L.P.$1.2M0.2975,0000%+$00.01
1492 Capital Management, LLC$1.15M0.2871,9290%+$00.64
Nuveen$1.15M0.2871,7380%+$0<0.0001
Charles Schwab$1.08M0.2667,300-2.51%-$27,763.96<0.0001
Wellington Management Company$1.05M0.2565,413+134.62%+$601,637.74<0.0001
Ameriprise Financial$830,626.000.251,817-47.49%-$751,245.49<0.0001
Rafferty Asset Management Llc$827,148.000.251,600New+$827,148.00<0.01
UBS$825,802.000.251,516+157.49%+$505,089.59<0.0001
D. E. Shaw & Co.$771,508.000.1948,129-4.8%-$38,904.82<0.01
Citigroup$753,185.000.1846,986+1,220.57%+$696,150.30<0.01
Dimensional Fund Advisors$729,910.000.1845,534-52.46%-$805,395.27<0.0001
GOLDEN CAPITAL MANAGEMENT LLC$689,691.000.1743,025+230.96%+$481,300.920.02
Hussman Strategic Advisors Inc$673,260.000.1642,000New+$673,260.000.16
Morgan Stanley$638,250.000.1539,816-36.09%-$360,386.19<0.0001
Pura Vida Investments LLC$561,050.000.1435,000-90.31%-$5.23M0.4
RhumbLine Advisers$514,026.000.1232,067+3.36%+$16,719.03<0.0001
Ohio Strs$506,000.000.1231,600-23.11%-$152,120.25<0.01
Bank of America$486,046.000.1230,321-20.77%-$127,438.60<0.0001
Renaissance Technologies$378,000.000.0923,600-35.87%-$211,423.73<0.01
Susquehanna International Group$331,324.000.0820,669-53.12%-$375,358.40<0.0001
Clearline Capital LP$331,212.000.0820,6620%+$00.03
Barclays$325,000.000.0820,336-41.02%-$226,042.49<0.0001
Citadel Advisors LLC$284,212.000.0717,730+427.21%+$230,303.09<0.0001
Financial Advisory Group$248,802.000.0615,521+19.2%+$40,075.060.05
Deutsche Bank$244,538.000.0615,255-5.11%-$13,176.68<0.0001
T. Rowe Price$232,000.000.0614,459+8.37%+$17,922.68<0.0001
MetLife Investment Management$218,729.000.0513,6450%+$0<0.01
Jane Street Capital$208,149.000.0512,985-47.09%-$185,242.19<0.0001
American International Group$198,596.000.0512,389-0.85%-$1,699.18<0.01
Two Sigma Advisers LP$192,360.000.0512,000-68.99%-$428,001.00<0.0001
Franklin Templeton Investments$188,673.000.0511,770New+$188,673.00<0.0001
Invesco$175,913.000.0410,974-61.36%-$279,354.46<0.0001
JPMorgan Chase$164,853.000.0410,284-38.15%-$101,694.62<0.0001
Wells Fargo$152,638.000.049,522+11.8%+$16,110.19<0.0001
New York State Common Retirement Fund$151,000.000.049,421+17.44%+$22,423.20<0.0001
LAZARD ASSET MANAGEMENT LLC$87,000.000.025,428-6.67%-$6,218.86<0.0001
Advisor Group Holdings Inc$54,388.000.013,393+4.34%+$2,260.16<0.0001
Legal & General$43,585.000.012,719-3.07%-$1,378.56<0.0001